What Is TB-500? Research Overview of the Thymosin Beta-4 Fragment Peptide

Overview

TB-500 is the common laboratory designation for a synthetic peptide fragment derived from Thymosin Beta-4 (T-Beta-4), a naturally occurring 43-amino-acid protein found in nearly all human and animal cell types. TB-500 corresponds to the region of Thymosin Beta-4 that contains the actin-binding sequence, and it is used in laboratory settings as a research tool to study actin dynamics and cell migration in cultured cells and animal models. This article is provided strictly for educational and scientific-literacy purposes.

Chemical Structure & Characteristics (LKKTET Domain)

Thymosin Beta-4 contains a highly conserved seven-amino-acid sequence, Leu-Lys-Lys-Thr-Glu-Thr (LKKTET), which is responsible for the protein's interaction with monomeric (G-actin) actin. TB-500 is designed to replicate this actin-binding domain in a smaller, more stable peptide fragment. Because it retains the LKKTET motif without the full-length protein sequence, TB-500 is frequently used by researchers as a simplified model compound for probing structure-function relationships in actin-regulatory proteins. In its lyophilized (freeze-dried) form, the peptide is typically supplied as a white powder for laboratory use.

Mechanism of Action (Actin-Binding, Cell Migration)

Actin is a core structural protein of the cytoskeleton, and its polymerization and depolymerization dynamics underlie fundamental cellular processes such as shape change, motility, and migration. In vitro studies indicate that the LKKTET domain allows Thymosin Beta-4 and TB-500 to sequester G-actin monomers, modulating the pool of actin available for filament assembly. Researchers investigate this actin-sequestering activity as a mechanism potentially linked to cytoskeletal remodeling and cell migration in laboratory models, including studies of endothelial cell and fibroblast motility in culture. These findings are considered a basis for further mechanistic inquiry into cytoskeletal regulation rather than an established clinical mechanism.

Research Considerations

For laboratories handling TB-500, standard peptide-research practices apply. Lyophilized peptide should be stored frozen and protected from light and moisture prior to use in accordance with the certificate of analysis provided with each batch. Purity verification (e.g., HPLC and mass spectrometry data) should be reviewed before use in any experimental protocol. All handling should occur within an appropriate laboratory setting using standard PPE, calibrated laboratory equipment, and institutional biosafety practices. This article does not provide, and Apex Molecular Labs does not endorse, any dosing, administration, or reconstitution instructions for use in humans or animals; any such protocols fall entirely within the scope of qualified research personnel operating under appropriate institutional oversight.

Preclinical Research Summary

Published preclinical literature has explored Thymosin Beta-4 and TB-500 primarily in animal models and cell-culture systems, examining topics such as actin monomer sequestration, cell migration assays, and angiogenesis-related signaling pathways. This body of research remains investigational and is not indicative of established outcomes in humans. Researchers interested in specific findings should consult primary peer-reviewed literature and evaluate study design, model system, and statistical rigor independently.

Research Use Only

TB-500 as offered in the research community, and any information referenced here, is intended strictly for in-vitro laboratory research and preclinical study by qualified researchers. It is not intended for human or veterinary use, diagnostic use, or as a food, drug, cosmetic, or dietary supplement. Apex Molecular Labs does not sell this compound for human or animal administration. This product is not currently listed for sale on our platform and is presented here for educational reference only, pending completion of internal certificate-of-analysis and quality-verification review.